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Abstract: G protein coupled receptors (GPCRs) are membrane proteins with many functional 
roles. This family of receptors is expansive, with several subfamilies. Here, a member of 
subfamily A, rhodopsin (Rho) is studied. Mutations in rhodopsin have been linked to the disease 
retinitis pigmentosa (RP). Some of these mutations have been found to disrupt the 
dimerization/oligomerization of Rho at the TM4/TM5 proposed dimerization interface, causing 
pathogenesis of RP. In this study, two mutations of transmembrane helix 5 were investigated for 
changes in dimerization and stability, cell trafficking, and signaling. It was found that the 
V209M and F220C mutations did not result in disruption of dimerization of Rho.  
Abbreviations: GPCR, G protein-coupled receptor; Rho, rhodopsin; RP, retinitis pigmentosa; 
TM, transmembrane helix/helices; GDP, guanine diphosphate; GTP, guanine triphosphate; PIE-
FCCS, Pulsed-interleaved excitation fluorescence cross-correlation spectroscopy; GFP, green 
fluorescent protein. 
Introduction 
 Heterotrimeric guanine nucleotide–binding protein (G protein)–coupled receptors, or 
GPCRs, are a large family of cell surface receptors responsible for cell signaling.1 Understanding 
GPCRs is integral for modern medicine, as GPCR signaling regulates bodily functions including 
sensation, growth, and hormonal responses. There are several subfamilies of GPCRs categorized 
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by intracellular response activation to variant extracellular stimuli. Some extracellular stimuli 
GPCRs respond to include light and small molecules such as hormones, cytokines, 
neurotransmitters, and other ligands.1 GPCRs have 7 transmembrane α-helices that associate 
with heterotrimeric G proteins: α, β, and γ. The inactive Gα binds GDP and is complexed with β 
and γ. When ligand binds the GPCR and becomes activated, Gα exchanges GDP for GTP and 
dissociates from βγ. The G proteins activate or inhibit various cell signaling pathways.1–3 
Subfamily A accounts for about 90% of GPCRs, rhodopsin belongs to this subfamily.2 
 Rhodopsin (Rho) was the first to have structure resolved through X-ray crystallography 
and serves as a model for structural study of GPCRs, as GPCRs are highly conserved.4 
Rhodopsin is a protein found in the retina that is essential for vision in low light conditions. 
Mutations in rhodopsin have been found to result in retinitis pigmentosa, a degenerative disease 
of the retina.5,6 Several Class II mutations have been identified, in which protein misfolding or 
instability causes RP pathogenesis.6 Understanding the pathophysiology of mutations of 
rhodopsin could help in targeting the disease for treatment.  
Research evidence shows that GPCRs can form dimers and oligomers.7 However, GPCR 
dimerization functionality and stability is still unclear.7,8 Rhodopsin transmembrane helices 4 
(TM 4) and 5 (TM 5) interactions are thought to be a site of dimerization interface.7,9 The goal of 
this project was to introduce site-specific mutations of specific amino acids involved in the 
proposed TM4/TM5 rhodopsin dimerization interface. In this study, the V209M and F220C 
mutations in Rho were investigated for their effects on dimerization.  
PIE-FCCS (or pulsed-interleaved excitation fluorescence cross-correlation spectroscopy) 
was used in the determination of oligomerization state of the Rho mutants. Use of PIE-FCCS 
allows for study of rhodopsin interactions in a live cell membrane. In this study, mammalian 
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cells are used to study murine rhodopsin oligomerization. This technique counts photons, with 
time delayed laser pulses at two wavelengths. The laser emits the pulses to excite different 
fluorescently tagged proteins such as mCherry (red at 561 nm) and eGFP (green at 488 nm), as 
used in this study. The cross-correlation data collected would allow for the determination of 
potential oligomerization states of Rho.10,11 
My role in this project was focused on the culturing of mammalian cells and transfection 
of cells with mutant or wild-type plasmid DNA. The cells cultured were Cos-7 (African green 
tree monkey). Transfected cells were then analyzed via PIE-FCCS to determine if rhodopsin 
dimerization occurred.  
Experimental Methods 
Constructs:  
 The rod opsin-EGFP and rod opsin-mCherry constructs were made by amplifying mouse 
opsin cDNA using PCR. EcoR1 and BamH1 restriction sites were added at the 5’ and 3’ ends. For 
opsin-EGFP, the forward primer: GTGGGGAATTCGCCATGAACGGCACAGAGGG and the 
reverse primer: TCTGGGGATCCGGCTGGAGCCACCTGG were used to do this. For opsin-
mCherry, the forward primer: GTGGGGAATTCGCCATGAACGGCACAGAGGG and the 
reverse primer: TCTGGGGATCCCGGGCTGGAGCCACCTGG were used. The pEGFP-N3 and 
pmCherry-N1 vectors (Clontech, Mountain View, CA) were used for cloning of respective 
amplified DNA. The Groves Lab at UC Berkeley provided Src16-eGFP/mCH and Src13-GCN4-
eGFP/mCH plasmids used as negative and positive dimer controls, respectively.  
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Phusion high-fidelity DNA polymerase (New England Biolabs, Ipswich, MA) was used to 
construct the RP-causing rod opsin mutants according to the manufacturer’s protocol. The 
composition of each construct was confirmed by Sanger DNA sequencing (GeneWiz, Inc).  
Cos7 cell culture: 
The Cos7 cells used in these experiments were obtained from ATCC (CRL-1651). Cos7 
cells were cultured with Dulbecco’s modified Eagle’s medium (DMEM 1X + GlutaMAX, Life 
Technologies, Carlsbad, CA) with 10% fetal bovine serum (FBS, Life Technologies, Hyclone, 
Logan, UT) and 1% penicillin/streptomycin (BioReagent, Sigma-Aldrich, St. Louis, MO). 
Cultures were incubated at 37 ̊C with CO2 at ~5-10%, with 100 % humidity. Cos7 cells were 
cultured on 100×20 mm tissue culture plates (Falcon, Corning Inc., Corning NY). Cell cultures 
were split at ~80-90% confluency and were not split above passage 18.  
Cos7 transfection and prep for imaging:  
Cos7 cells were split into 35×10 mm gamma-irradiated glass bottom culture dishes 
(MatTek, Ashland, MA) for transfection and imaging. For transient transfection, Lipofectamine 
2000 transfection reagent (Life Technologies) was used (2.5 µL) along with DMEM media with 
reduced phenol red (~31.25 µL). About 180 ng of each fluorescent plasmid were used in each dish. 
This procedure was done the day prior to imaging, allowing for ~24 hours of incubation.  
In preparation for imaging, transfected cells were washed with PBS and then Opti-MEM I 
media without phenol red (Life Technologies). This was done approximately 1 hour prior to PIE-
FCCS imaging and data collection.  
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Figure 1: Shows the custom scope set-up for PIE-FCCS experiments. Taken from reference 12. 
Pulsed-interleaved excitation-fluorescence cross-correlation spectroscopy (PIE-FCCS): 
PIE-FCCS experiments were conducted on a custom-built instrument, with procedure as 
described by Smith (2015).10 A scheme of this spectroscopy is shown above (Figure 1).12 There 
are two pulsed excitation beams at 488 nm and 561 nm (LL01-488-12.5 and LL02-561-12.5, 
Semrock, Rochester, NY), ideally targeting eGFP and mCherry fluorescent proteins, respectively. 
These beams are split and filtered, coming from a supercontinuum fiber laser (SuperK NKT 
Photonics, Birkerød, Denmark).  The laser pulses are temporarily separated by ~50 ns to prevent 
false-positives in cross-correlation. The two beams are then overlapped by a dichroic beamsplitter 
(LM01-503-25, Semrock) and redirected by a dichroic mirror (zt488/561rpc, Chroma Technology 
Corp., Bellows Falls, VT) to the microscope, where the excitation beams are direct to the objective 
Live cell membrane 
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and resulting emission signals are collected, then passes through a laser-blocking filter 
(zet488/561m, Chroma Technology Corp., Bellows Falls, VT) and then directed through the 50µm 
pinhole (Thorlabs). A long-pass filter (FF560-FDi01-25x36, Semrock) then splits the emission 
beam(s) into red and green signals, two bandpass filtered (FF01-621/69-25 and FF01-520/44-25 
Semrock) SPAD detectors (Micro Photon Devices, Bolzano, Italy) where photon counts are 
measured. A time-correlated single-photon counting (TCSPC) device (Picoharp 300, PicoQuant, 
Berlin, Germany) was used to record and process the raw fluctuating fluorescence data.  
 
Results and Discussion 
Constructs: 
The suspected RP-causing mutants constructed were V209M and F220C. These mutations 
are located on TM5, and are illustrated in the figure below (Figure 2). Murine cDNA was used in 
constructs because of their homology to human Rho (~95%). The proposed dimerization interface 
implicates TM 4 and TM 5.7,12 Based on this, it was investigated whether the V209M and F220C 
mutations disrupted the dimerization interface and were causatively implicated in pathogenesis of 
retinitis pigmentosa. These constructs were transiently transfected into Cos7, mammalian cells. 
The expression of these constructs was observed through PIE-FCCS experiments.  
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Figure 2: Shows the proposed TM4/TM5 dimerization interface of Rho. Amino acid sequence of 
TM5 of murine and human Rho is shown, along with locations of mutations V209M and F220C. 
The crystal structure shows TM5 locations of V209M and F220C mutations.  Suspected RP-
causing mutation V209M colored navy blue. Suspected RP-causing mutation F220C colored red.  
Cos7 cell transfection: 
 The Cos7 cell line is an immortalized line of African green tree monkey kidney cells. These 
cells were chosen for these experiments for their large, uniform peripheral membrane; as the 
natural layout of the cells allows for ease of observing interactions in the plasma membrane in 
optical imaging.12  In Figure 3, transfected Cos7 cell images are shown for wild-type and mutations 
V209M and F220C.  
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Figure 3: This figure shows the fluorescent expression of mCherry and eGFP tagged 
proteins in wild-type Rho, V209M mutant Rho, and F220C mutant Rho. Cos7 cells were 
transiently transfected with respective constructs. 
Pulsed-interleaved excitation-fluorescence cross-correlation spectroscopy (PIE-FCCS): 
 PIE-FCCS experiments enabled the quantification of dimerization affinities in the 
rhodopsin constructs. Transiently transfected Cos7 cells were observed with the custom scope, as 
mentioned previously and detailed in publication (10). Wild-type Rho, V209M mutant Rho, and 
F220C Rho were used and compared. Fluorescent tags were added to Rho, either mCherry (red) 
or eGFP (green). If dimerization occurred, cross-correlation would be observed in the PIE-FCCS 
data collected. Figure 4 shows representative PIE-FCCS curves, where wild-type in comparison 
to mutants V209M and F220C show no significant difference. These mutations did not disrupt the 
dimerization of rhodopsin.   
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Figure 4: This figure shows PIE-
FCCS results as cross-correlation 
curves. The green indicates eGFP, 
red indicates mCherry, and blue 
for cross-correlation. These curves 
show that there was no observable 
difference between wild-type Rho 
and the RP-causing mutants: 
V209M and F220C. This means 
that dimerization was not disturbed 
because of these mutations.13 
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Conclusion 
 In this project, rhodopsin mutations were investigated in whether their retinitis pigmentosa 
pathogenic effect was based on the disruption of rhodopsin dimerization. The transmembrane 
helices 4 and 5 (TM4 and TM5) have been proposed as a dimerization interface of rhodopsin 
previously.7,9 The RP-causing mutations V209M and F220C are located on TM5 of rhodopsin. 
Constructs were made, as described previously, of these mutations as plasmid DNA with 
fluorescent fusion proteins mCherry and eGFP. Mammalian cells were cultured, and then 
transiently transfected with plasmid DNA. Expression and cross-correlation in Cos7 cells was 
obtained and measured through PIE-FCCS experiments. There was no difference in rhodopsin 
dimerization found between wild-type rhodopsin and RP-causing mutants V209M and F220C, 
based on the data collected in this project. The mechanism of these mutations in retinitis 
pigmentosa remains unclear.  
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Appendix I- Safety 
Laboratory Training: Laboratory equipment and protocol training were provided by University 
of Akron graduate student William D. Comar. Training included mammalian cell culture, transient 
transfection protocol, transformation, and other laboratory molecular biology experiments. The 
University of Akron graduate student D. Paul Mallory conducted PIE-FCCS experiments and 
collected data.  
Biohazard Safety: Gloves were worn when working with biological substances. Sterile protocol 
was followed while working with live mammalian cell cultures. All glassware and pipette tips that 
encountered any biological substances were discarded in separate, biohazard waste containers. 
Liquid biological waste was bleached to prevent further growth before being disposed of. The 
Department of Environmental and Occupational Health and Safety disposed of biohazard waste 
containers.  
 
